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INTRODUCTION
Benign paroxysmal positional vertigo (BPPV) is the most com-
mon cause of dizziness, responsible for about 20% of cases (1, 
2). Diagnosis is simple compared to those of other dizziness-re-
lated diseases since specific nystagmus due to excitement of the 
semicircular canal can be revealed by a careful history combined 
with Frenzel glass or video imaging.
  When the otolith is displaced from the utricule to the rotation-
al movement-detecting semicircular canal, severe dizziness is 
experienced due to the reaction of the semicircular canal. The 
displacement of the otolith to the semicircular canal is the most 
convincing theory to explain nystagmus and the associated 
symptoms, serving as the basic concept for canalith reposition-
ing procedures (CRPs). There are many types of CRPs, catego-
rized by the affected semicircular canal and the type of otolith. 
Regardless of affected canal, BPPV is shown to have a high treat-
ment rate by CRPs (3, 4). 
  Even though BPPV may be easily treated with CRPs, BPPV 
patients who visit a non-ENT clinic or emergency room often 
experience sustained symptoms and are treated with only medi-
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cation (vestibular suppressants, antiemetics) because non-ENT 
doctors are often unaware of BPPV and CRP treatment options. 
In these cases, accurate diagnosis is delayed and treatment may 
be difficult. 
  Although CRP is a relatively successful treatment for BPPV, 
recurrence is high, with a reported one-year recurrence rate of 
22.6-30% (5-7). So, recurrence can be an important prognostic 
factor. Many factors may lead to recurrence, but to date there 
has been no study of the relationship between the time between 
symptom onset and CRP with recurrence.
  The purpose of this study is to demonstrate the effects of early 
repositioning therapy in patients with BPPV, especially with re-
gard to recurrence.
MATERIALS AND METHODS
This study included 138 patients diagnosed with BPPV in the 
emergency rooms and ENT out-patient clinics in Chung-Ang 
University Hospital and Samyook Medical Center between Jan-
uary-June 2009. The last follow-up visit took place in February 
2010, and follow-up durations ranged from 8 to 14 months. The 
study is prospective, using histories and the results of vestibular 
function tests. By taking careful histories, we were able to inves-
tigate the past history of vertigo, upper respiratory infection 
symptoms, otitis media, hypertension, tuberculosis, anemia, 
menstruation, occupation (to determine exposure to noise, agri-
cultural pesticides, use of vibrating machinery, etc.), medications 
(antihypertensives, anticonvulsants, muscle relaxants), and trau-
ma. Patients who had been treated for similar vertigo experienc-
es or who had been treated with medication prior to reposition-
ing therapy were excluded. We diagnosed BPPV in patients 
showing true vertigo by positional changes, rotating nystagmus 
on a Frenzel glass or video image, three consecutive nystagmus-
es, normal eye movement, no signs of spontaneous nystagmus, 
and normal neurological examinations including a fixation test 
and tandem gait and neurological exams (cerebellar function 
test, 12 cranial nerve test, and upper and lower limb motor/sen-
sory nerve test). 
  All treatments were performed by a skilled ENT doctor. For 
CRP of posterior canal BPPV, we applied a modified Epley’s 
maneuver, while a Barbecue maneuver was used for lateral ca-
nal BPPV. CRP was performed immediately after diagnosis, and 
we recorded the time between symptom onset and initial CRP. 
CRP was then performed daily until typical positional nystag-
mus disappeared. The patient was considered to be cured when 
whirling dizziness disappeared on a positional test and when 
positional nystagmus disappeared on a video nystagmus test. We 
instructed the patients to immediately return to the hospital if 
BPPV symptom recurred. The follow-up periods ranged from 
8-14 months, and patients who did not return voluntarily were 
called at approximately 2-3 month intervals to check for BPPV 
symptom. We defined recurrence as the reappearance of a simi-
lar whirling dizziness or reappearance of a similar rotating nys-
tagmus. 
  For emergency room patients, the time between symptom 
onset and initial treatment was generally a few hours, while that 
for clinic patients was generally greater than one day. Patients 
were thus classified into two groups: the early repositioning 
group (less than 24 hours to first treatment) and the delayed re-
positioning group (greater than 24 hours to first treatment) (Ta-
ble 1). The required numbers of CRPs and the recurrence rates 
were compared between the two groups. Statistical analysis was 
conducted using SPSS ver. 16.0 (SPSS Inc., Chicago, IL, USA), 
and cutoff points were determined according to logistic regres-
sion analysis. Pearson’s chi-square test, Fisher’s exact test and an 
independent t-test were used for analysis, and P-values less than 
0.05 were considered statistically significant.
RESULTS
Age, gender, causative factors, and frequency of the affected 
semicircular canal were included in the analysis. The mean age 
was 51.56±16.39 years (range, 9 to 80 years), 46 patients were 
males, 92 were females and most causative factors were idio-
pathic. Categorizing according to semicircular canal showed that 
77 patients were affected in the posterior canal, 48 were affect-
ed in the lateral canal and 13 were affected in multiple canals. 
There were no significant differences in age, gender, causative 
factors or affected semicircular canal between the two groups 
(Table 2). 
  The overall recurrence rate was 33.3% (46 out of 138 sub-
jects), and the average required number of treatments was 2.4 
times. The number of treatments and the recurrence rates were 
analyzed by age, gender, causative factors, affected semicircular 
canal, canalolithiasis or cupulolithiasis type, and no significant 
differences were observed (data not shown). In the logistic re-
gression analysis, considering only the sensitivity resulted in a 
cutoff point at hour 6. However, considering both sensitivity and 
specificity as well as the pre-determined result which showed 
that the number of treatments received, the cutoff point was set 
at 24 hours after symptom onset (Table 1). The average numbers 







≤6:>6 2.1:2.5 15.6:40.0 0.935 0.293
≤12:>12 2.1:2.5 19.6:40.2 0.848 0.402
≤24:>24 2.5:2.3 19.7:45.8 0.783 0.576
≤48:>48 2.4:2.4 23.5:47.4 0.674 0.598
CRP: canalith repositioning procedure.
*Receiver operating characteristic (ROC) curve was analyzed according 
to recurrence, area under ROC curve=0.677. Do Y-K et al.: Early Repositioning Can Reduce the Recurrence Rate of BPPV    115
of treatments received before full recovery was 2.5 in the early 
repositioning group and 2.3 in the delayed repositioning group, 
and the difference was not statistically significant (P=0.582). The 
recurrence rate was 19.7% in the early repositioning group and 
45.8% in the delayed repositioning group, a significant difference 
(P=0.002) (Table 2).
  Classifying the patients according to recurrence, we found 
that more males suffered from recurrence, although the gender 
difference was not statistically significant (Table 3). No other fac-
tors were found to be significant. 
DISCUSSION
Benign paroxysmal positional vertigo is a common disease with 
a life-time prevalence of 2.4% (8). Patients with the disease of-
ten visit the emergency room due to sudden dizziness. However, 
such patients are often not correctly diagnosed or treated, just 
receiving a fluid injection and antiemetics before being dis-
charged with vestibular suppressants and drugs to improve blood 
circulation. 
  Many opinions regarding BPPV treatment have existed. Since 
the spontaneous recovery rate is high and most of the patients 
are older, some specialists support simple observation, whereas 
others choose medication therapy because it is economical, con-
venient and yields rapid results (9). But, repositioning therapy 
has a remarkably higher alleviation rate and a shorter recovery 
time. Therefore, it is possible to prevent habitualization and fear 
of dizziness since the return to normal life is rapid and the symp-
tom duration is short. As a result, repositioning therapy is widely 
used as the primary BPPV treatment (7, 10, 11), and its effec-
tiveness has been shown through conventional studies (7), meta 
analyses (12), case-control studies (10, 13), and cohort studies 
(14). There have been reports that BPPV patients who received 
repositioning therapy in the emergency room or family medicine 
clinic showed more improvement compared to that of a control 
group. It has also been reported that decreased symptom dura-
tion has lead to improved quality of daily life for affected indi-
viduals (15). 
  In this study, we analyzed the relationship between the time 
of initial CRP treatment, the number of CRP treatments, and 
prognosis.
  Initailly we hypothesized that early treatment may reduce the 
number of treatments necessary for complete remission based 
on below explanations. First, when repositioning therapy is de-
layed, the probability of cupulolithiasis increases, leading to dif-
ficulties in otolith displacement using only a simple positional 
maneuver. Also, the time required for stabilization after reposi-
tioning therapy is extended, and longer periods of clinical stabi-
lization are difficult to achive (16). Second, as treatment is de-
Table 2. Subject demographic characteristics and results of canalith repositioning maneuvers according to group 
Early repositioning group  
(≤24 hours, n=66) 
Delayed repositioning group 
(>24 hours, n=72)
P-value
Age (year) 50.62±16.79 52.41±16.09 0.127*
Gender (male:female) 25:41 21:51 0.399
†
Etiology (trauma/viral/idiopathic) 2/4/60 5/3/64 0.497
‡
Mean follow-up period (month) 9.97±2.56 9.37±2.46 0.969*
Canal involvement  
(posterior canal/horizontal canalolithiasis/horizontal cupulolithiasis/mixed type) 36/19/6/5 41/9/14/8 0.072
†
Average symptom duration (hour) 10.87±8.07 516.16±955.74 <0.001
No.of repositionings until cure 2.50±1.33 2.34±1.34 0.582*




‡Fisher’s exact test was used. 
Table 3. Subject demographic characteristics and results of canalith repositioning maneuvers according to recurrence 
Recurrence group 
(n=46)
Non-recurrence group  
(n=92)
P-value
Age (year) 50.11±16.81 54.46±15.31 0.112*
Gender (male:female) 21:25 25:67 0.107
†
Etiology (trauma/viral/idiopathic) 3/5/38 4/2/86 0.233
‡
Mean follow-up period (month) 9.92±2.02 9.40±1.83 0.899*
Canal involvement  
(posterior canal/horizontal canalolithiasis/ horizontal cupulolithiasis/mixed type) 22/7/11/6 55/21/9/7 0.077
†
Average symptom duration (hour) 404.07±771.10 205.12±701.99 0.073*
No. of repositionings until cure 2.00±0.76 2.49±1.40 0.034*
*Independent t-test. 
†Chi-square test. 
‡Fisher’s exact test was used. 116    Clinical and Experimental Otorhinolaryngology   Vol. 4, No. 3: 113-117 , September 2011
layed, the duration of dizziness is increased, and the central ner-
vous system needs more time to readapt after repositioning 
therapy. Additionally, the extended dizziness results in escalated 
patient fear and low compliance, which reduces overall treatment 
efficacy. But, in our study, The correlation between the time be-
tween symptom onset and initial treatment and the number of 
treatments required was not statistically significant (P=0.582) 
(Table 2). 
  Our repositioning therapy and assessment were conducted 
one day interval for the following two reasons. First, since BPPV 
is due to the displacement of the otolith, symptoms are instantly 
cured upon repositioning. Second, we wanted to exclude biases 
due to the high spontaneous recovery rate, 30% in the first week 
and 64% in the first month (17). There are many different varia-
tions in the frequency of repositioning treatments (it may be 
performed only once (18), performed a fixed number times per 
visit or performed repeatedly until dizziness or nystagmus dis-
appears (19)). However, no differences between these variations 
have been found on short-term follow-up. 
  The recurrence rate for the early repositioning group was sig-
nificantly lower than that of the delayed repositioning group 
(P=0.002) (Table 2). We offer possible explanations for this re-
sult. In the early repositioning group, the otolith is rapidly relo-
cated into the utricle and causes no anatomical deformities. In 
delayed repositioning, however, the otolith is aggregated and 
forms a heavier mass, often leading to recurrence. If the otolith 
remains in the semicircular canal for a period of time, it may 
partially obstruct the canal or prevent endolymphatic fluid ab-
sorption, the presumed the reason for endolymphatic hydrops, 
an anatomical deformity of the labyrinth. Also, repetitive hydrops 
leads to circulation difficulties in the macula and irreversible 
damage on the macular surface, and the resulting otoconia re-
peatedly enter the semicircular canal, increasing the rate of re-
currence (20). Also, as treatment is delayed, continuous stimula-
tion of the otolith leads to higher recurrence due to degenera-
tive changes in the labyrinth. 
  Dorigueto et al. (5) found a recurrence rate of 26% in 100 
BPPV patients one year after treatment. Del Rio et al. (6) re-
ported a recurrence rate of 22.6% in 104 patients over a 6-15 
month follow-up. Nunez et al. (7) calculated the yearly recur-
rence rate after repositioning therapy to be 15%. Blakely (21) 
showed 30% recurrence in patients, of which 10% were in the 
first year and the remaining 20% were between 18-36 months. 
Compared to these reports, our recurrence rate was high, 
33.3% over 8-14 months. This may be simply due to more actu-
al recurrence or to the fact that we more rigorously investigated 
recurrence. 
  In literature, the prognostic factors for repositioning therapy 
are age, gender, causative factors, pathogenesis, affected semicir-
cular canal, mastoid vibrator use, treatment method, treatment 
skill and treatment interval (22). In our study, age, gender and 
affected semicircular canal showed no statistical correlation with 
the number of treatments or with recurrence rate, similar to the 
results of Nunez et al. (7) (Table 3). Our study was idiopathic in 
many cases, and the use of mastoid vibrators was not analyzed 
due to lack of data.
  In conclusions, BPPV is one of the most common diseases in-
volving dizziness. Even though repositioning therapy is effec-
tive, further work is needed to address its high recurrence rate. 
The early performance of repositioning therapy has been shown 
to decrease recurrence and allow for early recovery due to the 
rapid relief of symptoms. Also, it may be necessary for non-ENT 
primary doctors to familiarize themselves with concept of BPPV 
and repositioning therapy so that early diagnosis and adequate 
consultation or treatment are achieved.
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